SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-001825
Filing Date
2023-10-10
Accepted
2023-10-10 08:10:13
Documents
13
Period of Report
2023-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e5109_8-k.htm   iXBRL 8-K 31113
2 EXHIBIT 99.1 e5109_ex99-1.htm EX-99.1 17987
  Complete submission text file 0001731122-23-001825.txt   230376

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE renb-20231004.xsd EX-101.SCH 3024
4 XBRL LABEL FILE renb-20231004_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE renb-20231004_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT e5109_8-k_htm.xml XML 3331
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

IRS No.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 231315791
SIC: 2834 Pharmaceutical Preparations